Natco Total Assets from 2010 to 2024

NATCOPHARM   1,337  13.80  1.02%   
Natco Pharma's Total Assets are increasing with slightly volatile movements from year to year. Total Assets are estimated to finish at about 72.5 B this year. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals
 
Total Assets  
First Reported
2012-03-31
Previous Quarter
69.1 B
Current Value
82.4 B
Quarterly Volatility
21.1 B
 
Yuan Drop
 
Covid
Check Natco Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Natco Pharma's main balance sheet or income statement drivers, such as Depreciation And Amortization of 2 B, Interest Expense of 180 M or Total Revenue of 42 B, as well as many indicators such as . Natco financial statements analysis is a perfect complement when working with Natco Pharma Valuation or Volatility modules.
  
This module can also supplement various Natco Pharma Technical models . Check out the analysis of Natco Pharma Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Natco Stock

Natco Pharma financial ratios help investors to determine whether Natco Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Natco with respect to the benefits of owning Natco Pharma security.